# US 2003/0208281 A1 · Method of and composition for preventing tissue damage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0208281 A1
- Document ID: US20030208281A1
- Status: Published application
- Kind: A1
- Application number: 09/759,166
- Filed: 2001-01-16
- Published: 2003-11-06
- Earliest claimed: 1988-05-31
- Assignees: University of Florida
- Inventors: Eugene P. Goldberg; James W. Burns
- Web page: https://patentgrep.com/patent/US20030208281A1

## CPC

- A61L 27/34: Macromolecular materials
- A61F 2/0077: {Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence)}
- A61K 31/727: Heparin; Heparan
- A61K 31/728: Hyaluronic acid
- A61K 31/79: Polymers of vinyl pyrrolidone
- A61L 17/145: {Coating}
- A61L 31/10: Macromolecular materials
- A61L 2400/18: Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

An improved method and composition for preventing damage to tissue and/or organs during surgery and during harvesting, implanting, manufacture and manipulation of bio-prostheses therefrom. Tissue surfaces and surgical articles involved in the surgery and bioprostheses are coated with a solution of a hydrophilic, polymeric material prior to manipulation of the tissue and/or organs during surgery. The composition comprises a solution of a polymeric material having a molecular weight of about 50,000 D or above having a concentration of from about 0.01% to about 15% by weight.

## Claims

### Claim 1

A method of protecting tissue and preventing tissue damage in surgery comprising providing surfaces involved in said surgery with a wet coating of a physiologically acceptable aqueous solution of a hydrophilic, polymeric material prior to manipulation of said tissue during said surgery, wherein:
A) said polymeric material is a water-soluble, biocompatible, pharmaceutically acceptable polypeptide, polysaccharide, excluding hyaluronic acid having a molecular weight above about 1,500,000, synthetic polymer, salt, complex or mixture thereof; and
B) said polymeric material has a molecular weight of about 50,000 D or above, and the concentration in said aqueous solution of said polymer is in the range of from about 0.01% to about 15% by weight, said molecular weight and concentration having values such that said aqueous solution is capable of providing wet coatings on said surfaces involved in said surgery.

### Claim 2 (depends on 1)

The method of claim 1 wherein said polymeric material is carboxymethylcellulose, PVP, hyaluronic acid, pharmaceutically acceptable salts or complexes thereof or mixtures thereof.

### Claim 3 (depends on 2)

The method of claim 2 wherein said polymeric material is carboxymethylcellulose or a pharmaceutically acceptable salt or complex thereof.

### Claim 4 (depends on 2)

The method of claim 2 wherein said polymeric material is PVP or a pharmaceutically acceptable salt or complex thereof.

### Claim 5 (depends on 2)

The method of claim 2 wherein said polymeric material is hyaluronic acid or a pharmaceutically acceptable salt or complex thereof.

### Claim 6 (depends on 1)

The method of claim 1 wherein said surgery is abdominal, peritoneal, pericardial, obstetric, gynecological, neurosurgical, arthroscopic, laparoscopic, endoscopic, orthopedic, plastic, reconstructive, prosthetic, ENT, dental, muscle or tendon.

### Claim 7 (depends on 1)

The method of claim 1 wherein said involved surfaces coated with said solution of polymeric material comprise tissue or surgical article surfaces or both.

### Claim 8

A method of protecting tissue and preventing tissue damage in surgery comprising providing surfaces involved in said surgery with a wet coating of a physiologically acceptable aqueous solution of a hydrophilic, polymeric material prior to manipulation of said tissue during said surgery, wherein:
A) said polymeric material is a water-soluble, biocompatible, pharmaceutically accept-able hyaluronic acid having a molecular weight above about 1,500,000, salt, complex or mixture thereof; and
B) the concentration in said aqueous solution of said hyaluronic acid, salt or complex is in the range of from about 0.01% to less than about 1% by weight, said molecular weight and concentration having values such that said aqueous solution is capable of providing wet coatings on said surfaces involved in said surgery.

### Claim 9 (depends on 8)

The method of claim 8 wherein said surgery is abdominal, peritoneal, pericardial, obstetric, gynecological, neurosurgical, arthroscopic, laparoscopic, endoscopic, orthopedic, plastic, reconstructive, prosthetic, ENT, dental, muscle or tendon.

### Claim 10 (depends on 8)

The method of claim 8 wherein said involved surfaces coated with said solution of polymeric material comprise tissue or surgical article surfaces or both.

### Claim 11

A surgical article having surfaces adapted for contacting tissue surfaces during surgery, said surfaces of said surgical article having a wet coating thereon, said wet coating comprising a physiologically acceptable aqueous solution of a hydrophilic, polymeric material wherein:
A) said polymeric material is a water-soluble, biocompatible, pharmaceutically acceptable polypeptide, polysaccharide, excluding hyaluronic acid having a molecular weight above about 1,500,000, synthetic polymer, salt, complex or mixture thereof; and
B) a molecular weight of about 50,000 D or above, and the concentration in said aqueous solution of said polymer is in the range of from about 0.01% to about 15% by weight, said molecular weight and concentration having values such that said aqueous solution is capable of providing wet coatings on said surfaces; or
a physiologically acceptable aqueous solution of a hydrophilic, polymeric material, wherein:
I) said polymeric material is a water-soluble, biocompatible, pharmaceutically acceptable hyaluronic acid having a molecular weight above about 1,500,000, salt, complex or mixture thereof; and
II) the concentration in said aqueous solution of said hyaluronic acid, salt or complex is in the range of from about 0.01% to less than about 1% by weight, said molecular weight and concentration having values such that said aqueous solution is capable of providing wet coatings on said surfaces.

### Claim 12

A method of protecting from damage tissues or organs during harvesting thereof from animals or humans, manufacture therefrom of bioprostheses and subsequent manipulations and implantations of said bioprostheses in animals or humans, comprising providing said tissue or organ surfaces with a wet coating of a physiologically acceptable aqueous solution of a hydrophilic, polymeric material prior to and during said harvesting, manufacture of bioprostheses, manipulations and implantations thereof, wherein:
A) said polymeric material is a water-soluble, biocompatible, pharmaceutically acceptable polypeptide, polysaccharide, excluding hyaluronic acid having a molecular weight above about 1,500,000, synthetic polymer, salt, complex or mixture thereof; and
B) said polymeric material has a molecular weight of about 50,000 D or above, and the concentration in said aqueous solution of said polymer is in the range of from about 0.01% to about 15% by weight, said molecular weight and concentration having values such that said aqueous solution is capable of providing wet coatings on said surfaces.

### Claim 13

A bioprosthesis comprised at least in part of tissue or an organ or part thereof of an animal or human, said tissue or organ or part thereof having a coating thereon of a physiologically acceptable aqueous solution of a hydrophilic, polymer material to protect said tissue or organ or part thereof from damage arising during harvesting thereof from said animal or human, manufacture of said bioprosthesis and manipulations and implantations of said bioprosthesis in animals or humans, wherein:
A) said polymeric material is a water-soluble, biocompatible, pharmaceutically acceptable polypeptide, polysaccharide, excluding hyaluronic acid having a molecular weight above about 1,500,000, synthetic polymer, salt, complex or mixture thereof; and
B) said polymeric material has a molecular weight of about 50,000 D or above, and the concentration in said aqueous solution of said polymer is in the range of from about 0.01% to about 15% by weight, said molecular weight and concentration having values such that said aqueous solution is capable of providing wet coatings on said surfaces.

### Claim 14

A method of protecting from damage tissues or organs or parts thereof during harvesting thereof from animals or humans, subsequent manipulations and implantations of said tissues or organs or parts thereof in animals or humans, comprising providing said tissue and organ surfaces with a wet coating of a physiologically acceptable aqueous solution of a hydrophilic, polymeric material prior to and during said harvesting, manipulations and implantations thereof, wherein:
A) said polymeric material is a water-soluble, biocompatible, pharmaceutically acceptable polypeptide, polysaccharide, excluding hyaluronic acid having a molecular weight above about 1,500,000, synthetic polymer, salt, complex or mixture thereof; and
B) said polymeric material has a molecular weight of about 50,000 D or above, and the concentration in said aqueous solution of said polymer is in the range of from about 0.01% to about 15% by weight, said molecular weight and concentration having values such that said aqueous solution is capable of providing wet coatings on said surfaces.
